The primary risk associated with watchful waiting is the potential for the cancer to progress to a more advanced stage, making it more difficult to treat effectively. However, this risk is carefully managed through regular monitoring. Patients and their healthcare providers must be vigilant and ready to switch to active treatment if signs of progression are detected.